Pharmaceutical innovation
Field notes from the rooms where enterprise AI gets decidedNext room: Singapore & New York · 13 Nov 2026
On their agenda
Five priorities, mapped against profiled leaders
Drug development for rare diseases
Strategic partnerships
Growth & partnershipsPatient-centric approaches
Biotech collaboration.
AI strategy59%Digital transformation53%Operational efficiency48%Analytics & decisions38%Talent & culture36%Growth & partnerships31%Data platforms28%Data governance26%Customer experience21%
In the room
Boston, 26 Jun 2026
Working on now
Currently, Parul is leading strategic projects aimed at advancing Kiniksa’s therapeutic pipeline while cultivating partnerships to enhance drug development efforts
About
Parul Bordia Doshi is an experienced pharmaceutical executive based in Boston, MA, known for her pivotal roles in drug development and strategic leadership within dynamic biotech firms. She currently works at Kiniksa Pharmaceuticals, where she drives innovation in therapeutic solutions for rare diseases. Parul has a rich history of leveraging her scientific and managerial acumen to foster collaboration and execute transformative projects, continually aiming to enhance patient outcomes in the healthcare sector.
Summarised from public LinkedIn activity ·
Talks about
- 01Kiniksa Pharmaceuticals and therapeutic innovations
- 02Initiatives in rare diseases and patient advocacy
- 03Collaborations with industry leaders in biotech
- 04Engagement in biotech discussions on LinkedIn
Each topic links to the sessions, field notes and Pulse findings on that theme.
CIO summit Boston · See the AI conference for CIOs.
